Structure and function of dopamine receptors

[1]  E D Levin,et al.  Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. , 1999, Science.

[2]  A. Lang,et al.  Parkinson's disease. Second of two parts. , 1998, The New England journal of medicine.

[3]  A. Lang,et al.  Parkinson's disease. First of two parts. , 1998, The New England journal of medicine.

[4]  J. Sergeant,et al.  Differential distribution, affinity and plasticity of dopamine D-1 and D-2 receptors in the target sites of the mesolimbic system in an animal model of ADHD , 1998, Behavioural Brain Research.

[5]  D. Murphy,et al.  Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[6]  L. Rosén,et al.  Diversity and attention deficit hyperactivity disorder. , 1998, Journal of clinical psychology.

[7]  P Chambon,et al.  Impaired locomotion and dopamine signaling in retinoid receptor mutant mice. , 1998, Science.

[8]  J. Swanson,et al.  Association of the dopamine receptor D4 (DRD4) gene with a refined phenotype of attention deficit hyperactivity disorder (ADHD): a family-based approach , 1998, Molecular Psychiatry.

[9]  S. R. Nash,et al.  Dopamine receptors: from structure to function. , 1998, Physiological reviews.

[10]  P. Chambon,et al.  Regulation of dopaminergic pathways by retinoids: activation of the D2 receptor promoter by members of the retinoic acid receptor-retinoid X receptor family. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[11]  J. A. Chester,et al.  Mice Lacking Dopamine D4 Receptors Are Supersensitive to Ethanol, Cocaine, and Methamphetamine , 1997, Cell.

[12]  M. Caron,et al.  Selective inhibition of adenylyl cyclase type V by the dopamine D3 receptor. , 1997, Molecular pharmacology.

[13]  E. Borrelli,et al.  Absence of opiate rewarding effects in mice lacking dopamine D2 receptors , 1997, Nature.

[14]  M. Gill,et al.  Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism , 1997, Molecular Psychiatry.

[15]  A. Saiardi,et al.  Antiproliferative Role of Dopamine: Loss of D2 Receptors Causes Hormonal Dysfunction and Pituitary Hyperplasia , 1997, Neuron.

[16]  Y. Fukumaki,et al.  Cloning and characterization of the 5'-flanking region of the human dopamine D4 receptor gene. , 1997, Biochemical and biophysical research communications.

[17]  A. Chorvatova,et al.  Inhibition of the T-type Ca2+ current by the dopamine D1 receptor in rat adrenal glomerulosa cells: requirement of the combined action of the G betagamma protein subunit and cyclic adenosine 3',5'-monophosphate. , 1997, Molecular endocrinology.

[18]  G. Roth,et al.  Interaction of nuclear factors from young and old rat brain regions with regulatory sequences of the D2 dopamine receptor gene promoter. , 1997, Brain research. Molecular brain research.

[19]  J. Surmeier,et al.  D2 dopamine receptors reduce N-type Ca2+ currents in rat neostriatal cholinergic interneurons through a membrane-delimited, protein-kinase-C-insensitive pathway. , 1997, Journal of neurophysiology.

[20]  A. Saiardi,et al.  Dopamine D2 receptors in signal transduction and behavior. , 1997, Critical reviews in neurobiology.

[21]  Jerrold S. Meyer,et al.  Principles of Neuropsychopharmacology , 1997 .

[22]  L. Chiodo,et al.  D2L, D2S, and D3 dopamine receptors stably transfected into NG108‐15 cells couple to a voltage‐dependent potassium current via distinct G protein mechanisms , 1996, Synapse.

[23]  C. Gerfen,et al.  D1 dopamine receptor-deficient mouse: cocaine-induced regulation of immediate-early gene and substance P expression in the striatum , 1996, Neuroscience.

[24]  J. Swanson,et al.  Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. , 1996, Molecular psychiatry.

[25]  R. Wise,et al.  The neurobiology of addiction , 2019, Annals of the New York Academy of Sciences.

[26]  C. Gerfen,et al.  A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[27]  R. Mark Wightman,et al.  Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter , 1996, Nature.

[28]  D. Piomelli.  Arachidonic Acid in Cell Signaling , 1993, Molecular Biology Intelligence Unit.

[29]  G. Uhl,et al.  Retained cocaine conditioned place preference in D1 receptor deficient mice. , 1995, Neuroreport.

[30]  A. Saiardi,et al.  Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors , 1995, Nature.

[31]  R. Tyndale,et al.  The human dopamine D5 receptor gene: cloning and characterization of the 5'-flanking and promoter region. , 1995, Biochemistry.

[32]  N J Cox,et al.  Association of attention-deficit disorder and the dopamine transporter gene. , 1995, American journal of human genetics.

[33]  E. Borrelli,et al.  Alternative Splicing of the Dopamine D2 Receptor Directs Specificity of Coupling to G-proteins (*) , 1995, The Journal of Biological Chemistry.

[34]  H. Schulman,et al.  The multifunctional calcium/calmodulin-dependent protein kinase: from form to function. , 1995, Annual review of physiology.

[35]  E. Nestler,et al.  Molecular mechanisms of drug reinforcement and addiction. , 1995, Annual review of neuroscience.

[36]  C. Gerfen,et al.  Altered striatal function in a mutant mouse lacking D1A dopamine receptors. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  Ming Xu,et al.  Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses , 1994, Cell.

[38]  J. Marshall,et al.  Amphetamine‐ and cocaine‐induced fos in the rat striatum depends on D2 dopamine receptor activation , 1994, Synapse.

[39]  A. Carlsson,et al.  Behavioral and neurochemical data suggest functional differences between dopamine D2 and D3 receptors. , 1994, European journal of pharmacology.

[40]  C. Konradi,et al.  Amphetamine regulates gene expression in rat striatum via transcription factor CREB , 1994, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[41]  K. Jakobs,et al.  G protein specificity in receptor-effector coupling. Analysis of the roles of G0 and Gi2 in GH4C1 pituitary cells. , 1994, The Journal of biological chemistry.

[42]  M. Caron,et al.  Desensitization, phosphorylation and palmitoylation of the human dopamine D1 receptor. , 1994, European journal of pharmacology.

[43]  J. Mallet,et al.  Transcription of the rat dopamine-D2-receptor gene from two promoters. , 1994, European journal of biochemistry.

[44]  D. M. Jackson,et al.  Dopamine receptors: molecular biology, biochemistry and behavioural aspects. , 1994, Pharmacology & therapeutics.

[45]  M. Biel,et al.  Molecular basis for Ca2+ channel diversity. , 1994, Annual review of neuroscience.

[46]  W. Doppler.  Regulation of gene expression by prolactin. , 1994, Reviews of physiology, biochemistry and pharmacology.

[47]  E. Villacres,et al.  The regulatory diversity of the mammalian adenylyl cyclases. , 1993, Current opinion in cell biology.

[48]  C. van Hartesveldt,et al.  Locomotor activity following intra‐accumbens microinjections of dopamine D1 agonist SK&F 38393 in rats , 1993, Synapse.

[49]  S. Fuchs,et al.  A novel short isoform of the D3 dopamine receptor generated by alternative splicing in the third cytoplasmic loop. , 1993, The Journal of biological chemistry.

[50]  E. Borrelli,et al.  Preferential coupling between dopamine D2 receptors and G-proteins. , 1993, Molecular endocrinology.

[51]  C. V. Hartesveldt,et al.  Effects of dopamine D1 antagonists SCH23390 and SK&F83566 on locomotor activities in rats , 1993, Pharmacology Biochemistry and Behavior.

[52]  S. Amara,et al.  Neurotransmitter transporters: recent progress. , 1993, Annual review of neuroscience.

[53]  M. Caron,et al.  Recent advances in the molecular biology of dopamine receptors. , 1993, Annual review of neuroscience.

[54]  S. Hyman,et al.  Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[55]  B. M. Cohen,et al.  Differential expression of c-fos and zif268 in rat striatum after haloperidol, clozapine, and amphetamine. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[56]  D. Sibley,et al.  Characterization of the 5′ flanking region of the human D1A dopamine receptor gene , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[57]  P. Worley,et al.  D1 Dopamine Receptor Activation of Multiple Transcription Factor Genes in Rat Striatum , 1992, Journal of neurochemistry.

[58]  K. Johnson,et al.  Neurobiology of cocaine abuse. , 1992, Trends in pharmacological sciences.

[59]  G. Koob.  Drugs of abuse: anatomy, pharmacology and function of reward pathways. , 1992, Trends in pharmacological sciences.

[60]  C. Gerfen.  The neostriatal mosaic: multiple levels of compartmental organization in the basal ganglia. , 1992, Annual review of neuroscience.

[61]  D. Grandy,et al.  Molecular biology of the dopamine receptors. , 1991, European journal of pharmacology.

[62]  J. Vincent,et al.  Different expression of the two dopaminergic D2 receptors, D2415 and D2444, in two types of lactotroph each characterised by their response to dopamine, and modification of expression by sex steroids. , 1991, Endocrinology.

[63]  Susan R. George,et al.  Cloning of the gene for a human dopamine D5 receptor with higher affinity for dopamine than D1 , 1991, Nature.

[64]  Philip Seeman,et al.  Cloning of the gene for a human dopamine D4 receptor with high affinity for the antipsychotic clozapine , 1991, Nature.

[65]  E. Roubos,et al.  Cloning and sequence analysis of brain cDNA encoding a Xenopus D2 dopamine receptor , 1991, FEBS letters.

[66]  M. Iadarola,et al.  Cocaine induces striatal c-fos-immunoreactive proteins via dopaminergic D1 receptors. , 1991, Proceedings of the National Academy of Sciences of the United States of America.

[67]  E. Borrelli,et al.  Differential expression of the mouse D2 dopamine receptor isoforms , 1991, FEBS letters.

[68]  M. Caron,et al.  Regulation of responsiveness at D2 dopamine receptors by receptor desensitization and adenylyl cyclase sensitization. , 1991, Molecular pharmacology.

[69]  T. Curran,et al.  Stimulus-transcription coupling in the nervous system: involvement of the inducible proto-oncogenes fos and jun. , 1991, Annual review of neuroscience.

[70]  M. Le Moal,et al.  Mesocorticolimbic dopaminergic network: functional and regulatory roles. , 1991, Physiological reviews.

[71]  A. Graybiel,et al.  Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartments and limbic subdivisions of the striatum. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[72]  C. Gerfen,et al.  Molecular cloning and expression of a D1 dopamine receptor linked to adenylyl cyclase activation. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[73]  W. Douglas,et al.  Dopamine (D2) or γ-aminobutyric acid (GABAB) receptor activation hyperpolarizes rat melanotrophs and pertussis toxin blocks these responses and the accompanying fall in [Ca2+]i , 1990, Neuroscience Letters.

[74]  G. F. Hess,et al.  A second molecular form of D2 dopamine receptor in rat and bovine caudate nucleus , 1990, Nature.

[75]  Sl Harris.  Amphetamine and cocaine induce drug-specific activation of the c-fos gene in striosome-matrix compartment and limbic subdivisions of the striatum , 1990 .

[76]  T. Curran,et al.  Regulation of proenkephalin by Fos and Jun. , 1989, Science.

[77]  M. Martres,et al.  Alternative splicing directs the expression of two D2 dopamine receptor isoforms , 1989, Nature.

[78]  B. Sommer,et al.  The dopamine D2 receptor: two molecular forms generated by alternative splicing. , 1989, The EMBO journal.

[79]  M. Iadarola,et al.  Temporal analysis of increases in c-fos, preprodynorphin and preproenkephalin mRNAs in rat spinal cord. , 1989, Brain research. Molecular brain research.

[80]  C. Strader,et al.  Structural basis of β‐adrenergic receptor function , 1989, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[81]  F. Bloom,et al.  Cellular and molecular mechanisms of drug dependence. , 1988, Science.

[82]  D. Grandy,et al.  Cloning and expression of a rat D2 dopamine receptor cDNA , 1988, Nature.

[83]  J. Bockaert,et al.  An islet activating protein-sensitive G protein is involved in dopamine inhibition of angiotensin and thyrotropin-releasing hormone-stimulated inositol phosphate production in anterior pituitary cells. , 1987, The Journal of biological chemistry.

[84]  R. Wise,et al.  A psychomotor stimulant theory of addiction. , 1987, Psychological review.

[85]  J. Mallet,et al.  Complete coding sequence of rat tyrosine hydroxylase mRNA. , 1985, Proceedings of the National Academy of Sciences of the United States of America.